Cargando…
Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
BACKGROUND: Double-blind randomized controlled trials have compared patients with chronic obstructive pulmonary disease (COPD) taking triple therapy, which can improve lung function, dyspnea, and quality of life and reduce acute exacerbation and mortality, with those taking long-acting muscarinic an...
Autores principales: | Liao, Kuang-Ming, Wang, Jhi-Joung, Ho, Chung-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257929/ https://www.ncbi.nlm.nih.gov/pubmed/37309394 http://dx.doi.org/10.2147/COPD.S404039 |
Ejemplares similares
-
Postoperative Complications After Coronary Artery Bypass Grafting in Patients With Chronic Obstructive Pulmonary Disease
por: Ho, Chung-Han, et al.
Publicado: (2016) -
Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease
por: Liao, Kuang-Ming, et al.
Publicado: (2015) -
The association between adherence and dementia in chronic obstructive pulmonary disease
por: Liao, Kuang-Ming, et al.
Publicado: (2019) -
A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Huang, Wei-Chun, et al.
Publicado: (2021) -
Incidence and relative risk for developing cancer among patients with COPD: a nationwide cohort study in Taiwan
por: Ho, Chung-Han, et al.
Publicado: (2017)